Physician profile
Khalid Abousy
NPI 1952358087
$68,308.15
in general payments reported to CMS, 2019-2025
48 companies · $4,607 in 2025
The $4,607 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $4,777 · 2021: $17K · 2022: $9,515 · 2023: $8,933 · 2024: $12K · 2025: $4,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,560 · Travel and Lodging: $1,816 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,763.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,560.00 |
| Travel and Lodging | $1,815.63 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16,388.29 | 2020-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $13,101.47 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $9,324.14 | 2021-2025 | Verquvo, Capvaxive |
| Cvrx, INC. | $3,684.69 | 2020-2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $2,818.06 | 2019-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $1,753.54 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,712.36 | 2019-2025 | Watchman Access System, Opticross, Lux-Dx Insertable Cardiac Monitor |
| Atricure, INC. | $1,706.15 | 2022-2024 | |
| Abbott Laboratories | $1,644.68 | 2019-2025 | Aveir, Mitraclip, Esprit |
| Astrazeneca Pharmaceuticals Lp | $1,578.72 | 2019-2025 | Lokelma, Farxiga |
| Novo Nordisk INC | $1,504.98 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $1,246.40 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $1,199.25 | 2022-2025 | Symplicity G3, Linq II, Onyx Frontier |
| Amgen INC. | $1,195.85 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $879.01 | 2019-2025 | Jardiance |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $757.13 | 2023-2025 | |
| Pfizer INC. | $728.37 | 2019-2025 | |
| Medtronic Vascular, INC. | $615.88 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $534.03 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $443.95 | 2019-2023 | |
| Abiomed | $424.26 | 2020-2025 | Impella |
| Janssen Scientific Affairs, LLC | $419.98 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $411.83 | 2022-2025 | |
| Heartflow, INC. | $404.72 | 2023-2024 | Ffrct |
| Lilly USA, LLC | $394.57 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Opsens INC. | $381.60 | 2019-2021 | |
| Amarin Pharma, INC. | $364.67 | 2019-2022 | |
| Edwards Lifesciences Corporation | $331.55 | 2019-2022 | |
| Chiesi USA, INC. | $306.13 | 2019-2024 | Kengreal |
| Recor Medical INC | $212.48 | 2025 | Paradise Ultrasound Renal Denervation System |
| Regeneron Pharmaceuticals, INC. | $205.32 | 2019-2022 | |
| Bridgebio Pharma, INC. | $170.86 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $158.89 | 2023-2024 | Assure Wcd |
| Gilead Sciences, INC. | $130.45 | 2019 | |
| Shockwave Medical, INC | $127.66 | 2021 | |
| Ionis Pharmaceuticals, INC. | $122.03 | 2025 | Tryngolza |
| Kowa Pharmaceuticals America, INC. | $110.88 | 2020-2022 | |
| Qorumpartners | $109.92 | 2022 | |
| Coala Life INC | $107.13 | 2022 | |
| Penumbra, INC. | $103.52 | 2025 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $97.30 | 2019-2022 | |
| Biotronik INC. | $91.49 | 2021-2022 | |
| Celonova Biosciences, INC. | $90.71 | 2019 | |
| Baxter Healthcare | $66.10 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $65.54 | 2019 | |
| Philips North America LLC | $49.62 | 2020 | |
| Amryt Pharma Holdings Ltd | $17.05 | 2023 | Juxtapid |
| Aegerion Pharmaceuticals, INC. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Abousy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.